Oncotherics Poland Sp. zo.o. is delighted to announce that it has secured a 11.7M PLN grant as part of the regional operational program of the …
Read more
OncoTherics Poland updates progress at LSBC 2019, Krakow
Read more
OncoTherics wins “best pitch” at LSBC Investor Conference, Krakow
OncoTherics is delighted to have won the “best company presentation” competition at the 2018 Central European Life Science Investment Conference this October, in Krakow, Poland. …
Read more
OncoTherics forms wholly owned subsidiary in Poland
OncoTherics is delighted to announce the formation of OncoTherics Poland Sp.Zo.o., a wholly owned subsidiary of OncoTherics Limited, formed specifically to pursue the development of …
Read more
OncoTherics wins RESI Innovation Challenge competition
OncoTherics has won an International Innovation Challenge competition, and a chance to “pitch” at the upcoming RESI Investor conference this April, to be held at …
Read more
OncoTherics signs MoU with University Health Network (UHN), Toronto
OncoTherics and University Health Network (UHN), Toronto have signed a memorandum of understanding to progress the development of the company’s novel hypoxia-activated cancer drugs at …
Read more
OncoTherics wins Innovate UK Global Feasibility Study Award
OncoTherics wins Innovate UK Global Feasibility Study Award. Project Title: Exploiting Tumour Hypoxia in Precision Medicine: Advancing Novel Prodrug Therapies for Pancreatic Cancer with PMCC, …
Read more
OCT1002 shows promising results in prostate cancer research
Researchers at Ulster University have just published the latest results of a three-year study looking at OCT1002 in combination with hormone therapy in prostate cancer. The …
Read more
OncoTherics VOOM’s awareness for Pancreatic Cancer!
Over 400 people from around the world have voted for OncoTherics in the VOOM 2016 challenge! The VOOM 2016 challenge invites small and start-up businesses …
Read more
Dr Thomas Morris joins OncoTherics as Chief Medical Officer
OncoTherics is delighted to announce the appointment of Dr Thomas Morris as the company’s new Director and Chief Medical Officer. Dr Morris has worked in …
Read more